<DOC>
	<DOCNO>NCT00483496</DOCNO>
	<brief_summary>Commercially available external photoprotectors ( EP ) provide adequate protection ultraviolet A ( UVA ) visible wavelength . The propose medicinal product V0096 CR ( formula RV3131A-MV1166 ) broad spectrum EP ( bsEP ) . The rationale use V0096 CR ( formula RV3131A-MV1166 ) propose condition base ability broadly block UVA radiation visible light know trigger solar urticaria ( SU ) .</brief_summary>
	<brief_title>Evaluation Protection Activity Microfine Titanium Dioxide ( Ti02 ) , Pigmentary Ti02 Bisoctrizole Their Combinations Voluntary Patients With Idiopathic Solar Urticaria ( SU )</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Titanium dioxide</mesh_term>
	<criteria>Male female voluntary patient least 18 year old For female patient childbearing potential , negative pregnancy test baseline Patients clinical photobiological diagnosis idiopathic SU Patients underlying condition , underlying condition provide condition stable control Patients able follow instruction Written inform consent patient Children ( less 18 year old ) Pregnant lactate woman Women positive pregnancy test baseline Patients spontaneous occurrence SU lesion back within 3 day prior study entry Patients know allergy one ingredient contain test product Patients apply EP back skin previous 2 week study entry Patients apply topical corticosteroid back skin within 7 day prior study entry Patients applied emollient include white soft paraffin back skin within 2 day prior study entry Patients systemic exposure corticosteroid , antiinflammatories immunosuppressive agent within last 4 week prior study entry Patients oral antihistamine within last 2 day prior study entry Patients administer systemic topical photoactive medication phototherapy phototherapy alone within 1 week prior study entry Patients unstable noncontrolled underlying condition Patients able follow instruction Patients participate study within 3 month prior study entry Patients refuse give write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>